95 related articles for article (PubMed ID: 20229315)
21. A metabolite profiling method for diagnosis of precancerous cervical lesions and HPV persistence.
Walker H; Burrell M; Flatley J; Powers H
Bioanalysis; 2017 Apr; 9(8):601-608. PubMed ID: 28508693
[TBL] [Abstract][Full Text] [Related]
22. [Etiology and pathogenesis of precancerous lesions and invasive cervical carcinoma].
Panjković M; Ivković-Kapicl T
Med Pregl; 2008; 61(7-8):364-8. PubMed ID: 19097373
[TBL] [Abstract][Full Text] [Related]
23. Cervical cancer screening in immunocompromised women.
Nguyen ML; Flowers L
Obstet Gynecol Clin North Am; 2013 Jun; 40(2):339-57. PubMed ID: 23732035
[TBL] [Abstract][Full Text] [Related]
24. Frequency of HPV infection in pre-malignant lesions of cervix at the public institution "Institute for Health Protection of Women and Maternity" of Sarajevo Canton.
Kurtovic M; Mehmedbasic S; Drljevic K; Drljevic I
Med Arh; 2009; 63(1):24-7. PubMed ID: 19419122
[TBL] [Abstract][Full Text] [Related]
25. Cervical screening in genitourinary medicine clinics--what are we trying to achieve?
Bradbeer C; Navaratne L
Sex Transm Infect; 1999 Oct; 75(5):286-7. PubMed ID: 10616349
[No Abstract] [Full Text] [Related]
26. Human papillomavirus testing. Authors' comments.
Rebello G; Hallam N; Smart G; Farquharson D; McCafferty J
BMJ; 2001 Jul; 323(7304):109. PubMed ID: 11480413
[No Abstract] [Full Text] [Related]
27. Study on the main types and vaginal microecological status of persistent cervical high-risk human Papillomavirus infection in women of childbearing age.
Li X; Pan H; Sun Q
Minerva Med; 2021 Oct; 112(5):679-680. PubMed ID: 33337124
[No Abstract] [Full Text] [Related]
28. Eradication of cervical cancer in Latin America.
Bosch FX
Salud Publica Mex; 2016 Apr; 58(2):97-100. PubMed ID: 27557367
[No Abstract] [Full Text] [Related]
29. The role of human papilloma virus (HPV) in the aetiology of cervical cancer.
Malik AI
J Pak Med Assoc; 2005 Dec; 55(12):553-8. PubMed ID: 16438278
[No Abstract] [Full Text] [Related]
30. Guidelines for Papanicolaou test screening and follow-up.
Cox S; ;
J Midwifery Womens Health; 2012; 57(1):86-9. PubMed ID: 22251918
[No Abstract] [Full Text] [Related]
31. 2013 statement on human papillomavirus [corrected] test utilization.
Davis Davey D; Goulart R; Nayar R;
Cancer Cytopathol; 2014 Feb; 122(2):83-6. PubMed ID: 24376234
[No Abstract] [Full Text] [Related]
32. The detection of precancerous cervical lesions can be significantly increased.
Marshall Austin R
Arch Pathol Lab Med; 2003 Feb; 127(2):143-5. PubMed ID: 12562226
[No Abstract] [Full Text] [Related]
33. [The role of papilloma virus in development of cervix precancer and cancer (a literature review)].
Podistov IuI
Klin Lab Diagn; 2003 May; (5):44-50. PubMed ID: 12822310
[TBL] [Abstract][Full Text] [Related]
34. Microscopes, microbes and molecules: evolution of our understanding of the cause and natural history of the precursor lesions of squamous lower genital tract neoplasia.
Jones RW
J Obstet Gynaecol Res; 2006 Apr; 32(2):128-34. PubMed ID: 16594914
[No Abstract] [Full Text] [Related]
35. Statement on human papillomavirus DNA test utilization.
Solomon D; Papillo JL; Davey DD;
Arch Pathol Lab Med; 2009 Aug; 133(8):1276-7. PubMed ID: 19653725
[No Abstract] [Full Text] [Related]
36. Women who undergo HPV testing receive earlier detection and treatment of cervical precancers.
Printz C
Cancer; 2017 Dec; 123(24):4751. PubMed ID: 29205329
[No Abstract] [Full Text] [Related]
37. Women with Atypical Glandular Cells in Japan: The Clinical Significance and Utility of HPV-DNA Testing in Korean Women with Atypical Glandular Cells in Cervical Pap Tests.
Kawase R; Suzuki S
Cancer Invest; 2022 Mar; 40(3):234. PubMed ID: 34533072
[No Abstract] [Full Text] [Related]
38. [Clinical features and prognosis of cervical cancer in young women].
Cao L; Li X; Zhang Y; Li X; Wang Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 35(8):875-8. PubMed ID: 20818083
[TBL] [Abstract][Full Text] [Related]
39. Statement on HPV DNA test utilization.
Solomon D; Papillo JL; Davey DD
Diagn Cytopathol; 2009 Jul; 37(7):542-3. PubMed ID: 19459173
[No Abstract] [Full Text] [Related]
40. Diagnostic spectro-cytology revealing differential recognition of cervical cancer lesions by label-free surface enhanced Raman fingerprints and chemometrics.
Karunakaran V; Saritha VN; Joseph MM; Nair JB; Saranya G; Raghu KG; Sujathan K; Kumar KS; Maiti KK
Nanomedicine; 2020 Oct; 29():102276. PubMed ID: 32736038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
